Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Tuberculosis and Respiratory Diseases ; : 63-67, 2012.
Article in Korean | WPRIM | ID: wpr-101774

ABSTRACT

Although advances in multi-detector computed tomography (CT) technique make it possible to evaluate peripheral subsegmental pulmonary arteries, several studies have reported that small peripheral embolisms may still be missed. Recently, some reports demonstrated that dual-energy CT improved the capability to detect peripheral pulmonary embolism. We report a case of lymphoma presenting as disseminated microvascular pulmonary tumor embolism, detected by perfusion images using dual energy CT.


Subject(s)
Embolism , Lymphoma , Neoplastic Cells, Circulating , Perfusion , Pulmonary Artery , Pulmonary Embolism , Tomography, X-Ray Computed
2.
Yeungnam University Journal of Medicine ; : 187-191, 2011.
Article in Korean | WPRIM | ID: wpr-170828

ABSTRACT

Adult T-cell leukemia/lymphoma (ATLL) is a malignancy of mature T-cells caused by the human T-cell lymphotrophic virus type I (HTLV-I). HTLV-I is endemic in some areas in Japan, the Caribbean basin, and Africa but has low prevalence in South Korea. Patients with ATLL are susceptible to opportunistic infections such as cytomegalovirus (CMV) infection, but CMV infection in chronic ATLL is uncommon. Reported herein is a case involving a 44-year-old woman with chronic ATLL who presented the symptoms of fever and diarrhea. She was suspected to have acute-type ATLL but was later diagnosed with CMV colitis.


Subject(s)
Adult , Female , Humans , Africa , Caribbean Region , Colitis , Cytomegalovirus , Diarrhea , Fever , Human T-lymphotropic virus 1 , Japan , Leukemia-Lymphoma, Adult T-Cell , Opportunistic Infections , Prevalence , Republic of Korea , T-Lymphocytes , Viruses
3.
Tuberculosis and Respiratory Diseases ; : 459-463, 2011.
Article in Korean | WPRIM | ID: wpr-170813

ABSTRACT

Pulmonary complications occur in 40~60% of patients who receive hematopoietic stem cell transplantation (HSCT) and are a source of substantial morbidity and mortality. Acute eosinophilic pneumonia (AEP) is an uncommon, non-infectious pulmonary complication occurring in HSCT recipients. We now report the case of a 52-year-old man with AEP who was treated with allogenic HSCT due to acute myeloid leukemia. He complained of fever, cough and dyspnea 390 days after allogenic HSCT. He also had skin and hepatic graft versus host disease (GVHD). Hypoxemia, diffuse pulmonary infiltrates on a chest x-ray and eosinophilia in bronchoalveolar lavage fluid were also noted in several tests. His symptoms, pulmonary infiltrates, hepatic dysfunction and skin lesions rapidly improved after treatment with corticosteroid therapy. Our case supports the idea that AEP is a late phase non-infectious pulmonary complication and one of the manifestations of chronic GVHD.


Subject(s)
Humans , Middle Aged , Hypoxia , Bronchoalveolar Lavage Fluid , Cough , Dyspnea , Eosinophilia , Eosinophils , Fever , Graft vs Host Disease , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells , Leukemia, Myeloid, Acute , Pulmonary Eosinophilia , Skin , Thorax
4.
Intestinal Research ; : 217-224, 2011.
Article in Korean | WPRIM | ID: wpr-51736

ABSTRACT

BACKGROUND/AIMS: With the growing volume of screening colonoscopies, the incidence of rectal carcinoids and the number of endoscopic resections for rectal carcinoids are also increasing. However, the prognosis including recurrence and metachronous lesions after endoscopic resection is unclear. METHODS: The medical records of 255 patients who had undergone endoscopic resection for rectal carcinoids between October 1999 and April 2010 were retrospectively reviewed. RESULTS: The number of males was 150 (58.8%), and the mean age was 54.1 years (range, 27-85 years). Mean tumor size was 6.9 mm. In total, 162 cases (63.5%) were treated with endoscopic mucosal resection and 93 (36.5%) were treated with endoscopic submucosal dissection. Although endoscopic complete resections were achieved in all cases, the histological examination showed 47 cases with a positive resection margin (18.4%) and three with lymphovascular invasion (1.2%). In the 54 patients with a free resection margin, who were followed for more than 12 months, abdominopelvic computed tomography and endoscopy did not show recurrence after a median of 30.5 and 36 months, respectively. Three patients with lymphovascular invasion did not show recurrence during follow-up period of 13, 30, and 37 months, respectively. Metachronous rectal carcinoids were detected in four patients at 23, 58, 61, and 89 months, respectively, after initial endoscopic resection, leading to a second endoscopic treatment. CONCLUSIONS: Small rectal carcinoids completely resected grossly and pathologically without lymphovascular invasion appear to have low probability of short-term recurrence. However, considering the slow growth rate of carcinoids, long-term follow-up for recurrence and metachronous carcinoids is required.


Subject(s)
Humans , Male , Carcinoid Tumor , Colonoscopy , Endoscopy , Follow-Up Studies , Incidence , Mass Screening , Medical Records , Prognosis , Rectum , Recurrence , Retrospective Studies
5.
Journal of Korean Medical Science ; : 1634-1637, 2011.
Article in English | WPRIM | ID: wpr-112907

ABSTRACT

HMG-CoA reductase inhibitors (statins) are widely used to treat hypercholesterolemia. Among the adverse effects associated with these drugs are statin-associated myopathies, ranging from asymptomatic elevation of serum creatine kinase to fatal rhabdomyolysis. Fluvastatin-induced fatal rhabdomyolysis has not been previously reported. We describe here a patient with liver cirrhosis who experienced fluvastatin-induced fatal rhabdomyolysis. This patient had been treated with simvastatin (20 mg/day) for coronary artery disease and was switched to fluvastatin (20 mg/day) 10 days before admission. He was also taking aspirin, betaxolol, candesartan, lactulose, and entecavir. Rhabdomyolysis was complicated and continued to progress. He was treated with massive hydration, urine alkalization, intravenous furosemide, and continuous renal replacement therapy for acute renal failure, but eventually died due to rhabdomyolysis complicated by hepatic failure. In conclusion, fluvastatin should be used with caution in patients with liver cirrhosis, especially with other medications metabolized with CYP2C9.


Subject(s)
Humans , Male , Middle Aged , Coronary Artery Disease/complications , Fatal Outcome , Fatty Acids, Monounsaturated/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors/administration & dosage , Indoles/administration & dosage , Liver Cirrhosis/complications , Rhabdomyolysis/chemically induced , Simvastatin/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL